SULF2 and cancer: SULF2 up-regulation has been consistently observed in various types of cancer, including lung, breast, liver, brain, pancreatic, and gastric cancer [19–24] and was associated with an aggressive tumor phenotype and poor prognosis in patients with hepatocellular carcinoma [21], multiple myeloma [25], and esophageal cancer [26].